Risk of Etoposide-Related Acute Myeloid Leukemia in the Treatment of Epstein-Barr Virus—Associated Hemophagocytic Lymphohistiocytosis

No abstract is available for this paper.

• Publication year

  2002

• Venue

  International journal of hematology

• Publication date

  2002-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02982023PMID 11939264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma‐derived cell line, NK‐YS, by etoposide and cyclosporine A

  2001cited by this paper
• Secondary Acute Myelogenous Leukemia in Patients Previously Treated for Childhood Renal Tumors: A Report From the National Wilms Tumor Study Group

  2001cited by this paper
• Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

  2001cited by this paper
• Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

  2001cited by this paper
• SECONDARY LEUKEMIA IN A CHILD WITH NEUROBLASTOMA WHILE ON ORAL ETOPOSIDE: What is the Cause?

  2000cited by this paper
• Treatment Strategies for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (EBV-HLH)

  2000cited by this paper
• Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation.

  1999cited by this paper
• Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society.

  1999cited by this paper
• Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide‐containing regimens

  1998cited by this paper
• Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.

  1998cited by this paper
• Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina.

  1998cited by this paper
• Therapy-related AML after successful chemotherapy with low dose etoposide for virus-associated hemophagocytic syndrome.

  1998cited by this paper
• Resistance to etoposide‐induced apoptosis in a Burkitt's lymphoma cell line

  1998cited by this paper
• Secondary acute myelogenous leukemia following safe exposure to etoposide.

  1997cited by this paper
• HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society.

  1997cited by this paper
• ETOPOSIDE (VP‐16) INHIBITS EPSTEIN‐BARR VIRUS DETERMINED NUCLEAR ANTIGEN (EBNA) SYNTHESIS

  1995cited by this paper
• Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistocytosis (FHL).

  1994cited by this paper
• Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis.

  1994cited by this paper
• Langerhans cell histiocytosis and etoposide: risks vs. benefits.

  1994cited by this paper
• Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.

  1993cited by this paper
• Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for langerhans cell histiocytosis

  1993cited by this paper
• High Frequency of Etoposide (VP‐16)-Related Secondary Leukemia in Children with Non‐Hodgkin's Lymphoma

  1993cited by this paper
• Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

  1991cited by this paper
• Etoposide in recurrent childhood Langerhans' cell histiocytosis: An Italian cooperative study

  1988cited by this paper
• Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung.

  1987cited by this paper
• Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation.

  1985cited by this paper
• Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report.

  1979cited by this paper

• Efficacy and safety of ruxolitinib‐based regimen in the treatment of paediatric Epstein–Barr virus‐associated haemophagocytic lymphohistiocytosis

  2025cites this paper
• Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.

  2024cites this paper
• Etoposide Therapy of Cytokine Storm Syndromes.

  2024cites this paper
• Immune Effector Cell associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS).

  2023cites this paper
• Secondary Leukemia in a Patient With EBV-HLH Carrying Heterozygous STXBP2 Variant.

  2021cites this paper
• Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome–Hemophagocytic Lymphohistiocytosis

  2021cites this paper
• How can an internal medicine specialist save a patient with hemophagocytic lymphohistiocytosis (HLH)?

  2020cites this paper
• Factors predicting the recurrence of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol

  2019cites this paper
• エトポシドが奏功した重症Epstein-Barr virus関連血球貪食性リンパ組織球症の1成人例

  2019cites this paper
• Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.

  2019cites this paper
• A Rapid Cytologic Double Staining of Epstein-Barr Virus-encoded Small RNA and Cell Surface Markers for Diagnosis of Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis.

  2019cites this paper
• Successful Use of Etoposide for Severe Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in an Adult：A Case Report

  2019cites this paper
• Etoposide Therapy of Cytokine Storm Syndromes

  2019cites this paper
• Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan

  2018cites this paper
• Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society.

  2018influential citation
• Hemophagocytic Lymphohistiocytosis, Secondary

  2017cites this paper
• Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature

  2016cites this paper
• Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases

  2016cites this paper
• Prognostic factors of Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in children: Report of the Japan Histiocytosis Study Group

  2014cites this paper
• Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis.

  2012cites this paper
• Detection of T-cell receptor gene rearrangement in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis.

  2011cites this paper
• Acute promyelocytic leukemia following chemotherapy for EBV‐associated hemophagocytic lymphohistiocytosis

  2011cites this paper
• Clinical studies of hemophagocytic lymphohistiocytosis

  2011cites this paper
• Hemophagocytic Syndrome Associated with Hematologic Malignancies

  2011cites this paper
• Acute myeloid leukemia initially presenting as hemophagocytic lymphohistiocytosis--a case report and review of the literature.

  2010cites this paper
• The Inhibitory Effects of Chinese Herbal Effective Fractions on the Expression of EBV Early Antigen

  2009cites this paper
• Multiple organ failure and severe bone marrow dysfunction in two 18 year‐old Caucasian patients: Epstein–Barr virus and the haemophagocytic syndrome

  2008cites this paper
• [A case of therapy-related acute monocytic leukemia following low-dose of etoposide treatment for hemophagocytic lymphohistiocytosis].

  2007cites this paper
• Recognition and management of macrophage activation syndrome in juvenile arthritis

  2007cites this paper
• Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.

  2007cites this paper
• Immunotherapy of Familial Hemophagocytic Lymphohistiocytosis With Antithymocyte Globulins: A Single-Center Retrospective Report of 38 Patients

  2007cites this paper
• Etoposide‐related secondary acute myeloid leukemia (t‐AML) in hemophagocytic lymphohistiocytosis

  2007cites this paper
• Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein–Barr virus‐associated T‐cell lymphoma: Nuclear factor‐κB pathway as a potential therapeutic target

  2007cites this paper
• Infection-associated haemophagocytic syndrome associated with recurrent acute myeloid leukaemia/myelodysplastic syndrome: an autopsy case

  2006cites this paper
• Haemophagocytic syndromes in adults: current concepts and challenges ahead.

  2005cites this paper
• Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies

  2005cites this paper
• Haemophagocytic lymphohistiocytosis in Malaysian children

  2005cites this paper
• Epstein–Barr virus‐associated hemophagocytic syndrome as first presentation of Fanconi anemia

  2005cites this paper
• Secondary Acute Promyelocytic Leukemia Following Chemotherapy for Non-Hodgkin's Lymphoma in a Child

  2004cites this paper
• Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center.

  2003cites this paper